The direct costs of drug-induced skin reactions
| Autor: | Karina Jahnz-Różyk, Nina Kiepurska, Monika Szkultecka-Dębek, Elwira Paluchowska, Witold Owczarek |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male 0301 basic medicine medicine.medical_specialty Drug-Related Side Effects and Adverse Reactions Skin Diseases lcsh:Agriculture 03 medical and health sciences Indirect costs 0302 clinical medicine Pharmacotherapy Cost of Illness Health care Humans Medicine International Statistical Classification of Diseases and Related Health Problems Waste Management and Disposal lcsh:Environmental sciences health care economics and organizations Ecology Evolution Behavior and Systematics Retrospective Studies lcsh:GE1-350 adverse drug reactions 030201 allergy business.industry Medical record ICD 10 lcsh:S Public Health Environmental and Occupational Health ICD-10 Retrospective cohort study Middle Aged Service provider medicine.disease United States JGP Hospitalization National Health Fund 030104 developmental biology Pharmaceutical Preparations Emergency medicine Female direct costs Medical emergency business |
| Zdroj: | Annals of Agricultural and Environmental Medicine, Vol 24, Iss 2, Pp 190-193 (2017) |
| ISSN: | 1898-2263 1232-1966 |
| Popis: | [b] Abstract Objective.[/b] The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002-2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw. The analysis was carried out from the perspectives of the public payer and service provider. [b]Materials and method. [/b]The retrospective study was carried out in a group of 164 adult patients due to skin adverse drug reactions. Analysis was based on data from patient medical records and medical orders which provided information on the used resources, including diagnostic tests, medical consultations, medicinal products, hospitalisation duration, together with cost estimation, regardless of the treatment being the cause of the skin reaction. [b]Results[/b]. According to the International Statistical Classification of Diseases and Related Health Problems(ICD) diagnosis and scores, assigned by the National Healthcare Fund, it has been estimated that patient hospitalisation at the Department of Dermatology for skin drug reaction incurred costs at the average amount of €717.00 per patient. The complex diagnostics and pharmacotherapy of the same group of patients generated costs for the hospital at the average amount of €680 per patient. [b]Conclusions[/b]. As a result of the analysis, the therapy for skin adverse drug effects generates significant costs, both for the payer and the service provider. Since the costs are comparable, it seems that the pricing of medical procedures by the public payer is adequate for the costs incurred by the medical service provider. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|